2011
DOI: 10.1016/j.biomaterials.2011.05.011
|View full text |Cite
|
Sign up to set email alerts
|

Controlled release of DNA from poly(vinylpyrrolidone) capsules using cleavable linkers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
42
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
8
2

Relationship

4
6

Authors

Journals

citations
Cited by 46 publications
(42 citation statements)
references
References 38 publications
0
42
0
Order By: Relevance
“…35,37 Other approaches have relied on the post-fabrication treatment of hydrogen-bonded multilayers with short disulfide-containing linkers to introduce stabilizing crosslinkes that can be cleaved by reducing agents to promote film erosion and release incorporated agents. 3841 …”
Section: Resultsmentioning
confidence: 99%
“…35,37 Other approaches have relied on the post-fabrication treatment of hydrogen-bonded multilayers with short disulfide-containing linkers to introduce stabilizing crosslinkes that can be cleaved by reducing agents to promote film erosion and release incorporated agents. 3841 …”
Section: Resultsmentioning
confidence: 99%
“…Low-fouling PVP capsules assembled via hydrogen bonding and stabilized using covalent cross-linking were investigated as a potential carrier for the development of drug delivery [225] . Ng et al report that the capsules present relative stability and good cargo (fluorescently labelled plasmid DNA) retention over 48 h, which make these capsules very attractive for applications in drug and gene delivery [225] .…”
Section: Challenges Of Pvp For Applications In Pharmaceutical Industrmentioning
confidence: 99%
“…A major application for PVP is in micellar systems, [152][153][154][155][156][157] although PVP has also been used in liposomes, 158-160 nanostructured capsules, [161][162][163][164] and drug conjugates. A major application for PVP is in micellar systems, [152][153][154][155][156][157] although PVP has also been used in liposomes, 158-160 nanostructured capsules, [161][162][163][164] and drug conjugates.…”
Section: Poly(vinylpyrrolidone)mentioning
confidence: 99%